| Timothy J Shafer, PHARMD | |
|
77 Wainwright Dr, Walla Walla, WA 99362-3975 | |
| (509) 525-5200 | |
| Not Available |
| Full Name | Timothy J Shafer |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 77 Wainwright Dr, Walla Walla, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063669059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S016763 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Timothy J Shafer, PHARMD 251 Nw Ruby Ln, College Place, WA 99324-2201 Ph: () - | Timothy J Shafer, PHARMD 77 Wainwright Dr, Walla Walla, WA 99362-3975 Ph: (509) 525-5200 |
News Archive
Everist Genomics announced today that Executive Vice Chairman Alex Charlton will speak about its breakthrough CardioDefender Device at the Wearable Technologies Conference, January 30, 2012, in Munich.
Researchers of the TGF-beta and Cancer group of Bellvitge Biomedical Research Institute, in collaboration with King's College London, have unveiled the role of NADPH oxidase NOX4 as an inhibitor of the epithelial-amoeboid transition, a process that contributes to the migration and invasion of tumor cells.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the second quarter of 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 3, 2010.
A new study reports on the success of growing human liver cells on resorbable scaffolds made from material similar to surgical sutures. Researchers suggest that this liver tissue could be used in place of donor organs during liver transplantation or during the bridge period until a suitable donor is available for patients with acute liver failure.
The kidney is the most commonly transplanted organ in the United States, with more than 17,000 transplants performed each year. Following kidney transplant, patients are routinely placed on a regimen of immunosuppressant medications to prevent organ rejection, which often includes calcineurin inhibitors (CNIs) as the backbone medication of this regimen.
› Verified 4 days ago
Barry Patzer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2028 E Isaacs Ave, Walla Walla, WA 99362 Phone: 509-529-1917 | |
Wayne Rickords, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 N Wilbur Ave, Walla Walla, WA 99362 Phone: 509-529-2008 | |
Mr. Richard A Worthington, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Plaza Way, Walla Walla, WA 99362 Phone: 509-522-4672 Fax: 509-525-8985 | |
Dr. Jon Granbois, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 633 W Tietan St, Walla Walla, WA 99362 Phone: 509-529-1570 | |
Dr. Robert John Brawders, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-897-2055 | |
Hiwot Bekele, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2222 E Isaacs Ave, Apt # E 101, Walla Walla, WA 99362 Phone: 919-600-0436 | |
Mr. Barry Michael Mallard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-527-8000 Fax: 509-527-8183 |